[dbSelect] Could not connect to DB: 1040: Too many connectionsCould not execute 'SELECT r_filename, r_embargoed, UNIX_TIMESTAMP(r_pub_release_date) as rel_date FROM pressrelease WHERE r_id = 207716' on database eurekalert:
2002: Can't connect to local MySQL server through socket '/tmp/mysql.sock' (2) Andrea Richardson, M.D., Ph.D, Dana-Farber Cancer Institute Could not connect to DB: 1040: Too many connectionsCould not execute 'UPDATE multimedia SET m_hits = m_hits+ 1, m_total_hits = m_total_hits+ 1, m_pub_hits = m_pub_hits+ 1, m_total_pub_hits = m_total_pub_hits+ 1 WHERE m_id = 41894' on database eurekalert:
2002: Can't connect to local MySQL server through socket '/tmp/mysql.sock' (2)
[ Back to EurekAlert! ]

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute

Andrea Richardson, M.D., Ph.D, Dana-Farber Cancer Institute

Caption: Andrea Richardson, M.D., Ph.D, and her colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.

Credit: Sam Ogden

Usage Restrictions: None

Related news release: DNA marker predicts platinum drug response in breast, ovarian cancer


[ Back to EurekAlert! ]